The study, published in the Clinical Journal of Pain, compared the use of short and long acting opioids. This study is the first to show a significant difference in the effects of long-acting and short-acting opioids.
The 81 men who participated in the study were on a stable dose of an opioid medication for at least three months. Seventy-four percent of the men on long-acting opioids had low testosterone levels as compared to 34 percent of the men using short-acting opioids.
More Articles on Pain Management:
Advanced Pain Care in Texas Hires Dr. Ajay Suman
FDA Advisory Panel Approves Greater Restriction of Vicodin, Other Drugs
EIMindA, Purdue Pharma to Collaborate on Pain Management Research
